Atypical Small Cell Lung Cancer: A New Malignancy Characterized by Chromothripsis, Carcinoid Tumors, and Wild-type RB1 and TP53

Research output: Contribution to journalArticlepeer-review

Abstract

Small cell lung cancer (SCLC) and pulmonary carcinoid tumors are traditionally seen as unrelated, with SCLC linked to smoking and characterized by biallelic loss of RB1 and TP53 and rapid progression. Rekhtman and colleagues upend these assumptions by discovering an “atypical” SCLC that arises in nonsmokers with intact RB1 and TP53 loci, chromothripsis-induced oncogene amplifications on extrachromosomal DNA, and frequent synchronous carcinoid tumors.

Original languageEnglish (US)
Pages (from-to)8-10
Number of pages3
JournalCancer discovery
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2025

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Atypical Small Cell Lung Cancer: A New Malignancy Characterized by Chromothripsis, Carcinoid Tumors, and Wild-type RB1 and TP53'. Together they form a unique fingerprint.

Cite this